Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the full record of transactions filed by Coles N Anthony, Consejero. Director active across 2 companies, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 32 disclosures have been logged. Activity tracked since 13 August 2021. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Coles N Anthony
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
COLES N ANTHONY is an Administrateur at Cerevel Therapeutics Holdings, Inc. and Regeneron Pharmaceuticals, INC. He has 32 filings in total, and across the sampled recent filings the most common transaction nature is Levée d'options, with total buy and sell amounts of EUR 0 each between 2021-08-16 and 2026-01-06.